发明名称 N-2 substituted purines in oligonucleotides
摘要 This invention presents novel purine-based compounds for inclusion into oligonucleotides. The compounds of the invention, when incorporated into oligonucleotides are especially useful as "antisense" agents-agents that are capable of specific hybridization with a nucleotide sequence of an RNA. Oligonucleotides are used for a variety of therapeutic and diagnostic purposes, such as treating diseases, regulating gene expression in experimental systems, assaying for RNA and for RNA products through the employment of antisense interactions with such RNA, diagnosing diseases, modulating the production of proteins, and cleaving RNA in site specific fashions. The compounds of the invention include novel heterocyclic bases, nucleosides, and nucleotides. When incorporated into oligonucleotides, the compounds of the invention can be useful for modulating the activity of RNA.
申请公布号 US5808027(A) 申请公布日期 1998.09.15
申请号 US19960762587 申请日期 1996.12.10
申请人 ISIS PHARMACEUTICALS, INC. 发明人 COOK, PHILLIP DAN;RAMASAMY, KANDA S.;MANOHARAN, MUTHIAH
分类号 C07D473/16;A61K31/415;A61K31/70;A61K31/7042;A61K31/7052;A61K31/7076;A61K31/708;A61K31/7088;A61K38/00;A61K47/48;A61K48/00;A61P31/12;C07D473/18;C07D487/04;C07H19/04;C07H19/06;C07H19/10;C07H19/16;C07H19/167;C07H19/173;C07H19/20;C07H21/00;C07H21/02;C07H21/04;C07H23/00;C07J43/00;C12N9/02;C12N15/113;C12Q1/68;(IPC1-7):C07H21/00 主分类号 C07D473/16
代理机构 代理人
主权项
地址